Comparison of Different Low Volume Solutions Prior to Colonoscopy
NCT ID: NCT03698474
Last Updated: 2019-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
612 participants
INTERVENTIONAL
2018-10-25
2019-02-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy
NCT02956057
Comparison Between Coolprep and Picolyte for Bowel Cleansing
NCT01774175
Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT01649674
Comparison of the Effectiveness of Bowel Preparations Before Colonoscopy
NCT03242369
Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy
NCT01603654
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SPMC-S
Natrium picosulfate /Magnesium citrate ( Picoprep™, oral solution) 2L in the evening before colonoscopy
Natrium picosulfate / Magnesium citrate
bowel preparation formula
SPMC-D
Natrium picosulfate/ Magnesium citrate ( Picoprep™, oral solution) 1L in the evening and 1L in the morning before colonoscopy
Natrium picosulfate / Magnesium citrate
bowel preparation formula
PEGA-S
Polyethylene glycol / Ascorbic acid ( Moviprep™, oral solution) 2L in the evening before colonoscopy
Polyethylene glycol / Ascorbic acid
bowel preparation formula
PEGA-D
Polyethylene glycol / Ascorbic acid (Moviprep™, oral solution) 1L in the evening and 1L in the morning before colonoscopy
Polyethylene glycol / Ascorbic acid
bowel preparation formula
SULF-S
Natrium/ Kalium/ Magnesium sulfate ( Eziclen™, oral solution) 1 L in the evening before colonoscopy
Natrium/ Kalium/ Magnesium sulfate
bowel preparation formula
SULF-D
Natrium/ Kalium/ Magnesium sulfate ( Eziclen™, oral solution) 0,5 L in the evening and 0,5L in the morning before colonoscopy
Natrium/ Kalium/ Magnesium sulfate
bowel preparation formula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Natrium picosulfate / Magnesium citrate
bowel preparation formula
Polyethylene glycol / Ascorbic acid
bowel preparation formula
Natrium/ Kalium/ Magnesium sulfate
bowel preparation formula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active bowel inflammation
* pregnancy
* prior bowel resection
* any presence of serious medical conditions ( cardiac, renal, liver disease)
* inability to obtain valid data from subject
* active bowel bleeding
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculty Hospital Kralovske Vinohrady
OTHER_GOV
Tomas Bata Hospital, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Kojecky
Role: PRINCIPAL_INVESTIGATOR
KNTB Zlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty Hospital Kralovske Vinohrady
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BN102018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.